Results 101 to 110 of about 1,149,511 (200)

Forest plot of incidence of severe radiation pneumonitis.

open access: yes, 2018
Forest plot of incidence of severe radiation pneumonitis.
Kwan-Il Kim (5318012)   +5 more
core   +1 more source

Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Squamous cell carcinoma is a rare bladder cancer subtype with poor prognosis in advanced stages. Currently, there is no established systemic therapy, including immune checkpoint inhibitors, for this subtype. Case Presentation A 49‐year‐old man with pure bladder squamous cell carcinoma arising from a diverticulum with pelvic lymph ...
Kazuma Soya   +7 more
wiley   +1 more source

Main characteristics of the studies for radiation pneumonitis.

open access: yes, 2016
Main characteristics of the studies for radiation pneumonitis.
Wenwu He (2556745)   +6 more
core   +1 more source

Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances

open access: yesMedComm, Volume 7, Issue 9, September 2026.
The schematic outlines the key events of the abscopal effect. (Ignition) Local radiotherapy (RT) induces the release of immunogenic signals from the tumor, leading to dendritic cell (DC) activation. (Orchestration) In the tumor‐draining lymph node (TDLN), DCs prime naive T cells into cytotoxic T lymphocytes (CTLs), a process modulated by regulatory T ...
Yihong Dong   +5 more
wiley   +1 more source

Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside

open access: yesPrecision Radiation Oncology, Volume 10, Issue 3, Page 417-427, September 2026.
The dual immunomodulatory network of radiotherapy in hepatocellular carcinoma. Radiotherapy initiates its effects by inducing immunogenic cell death and DNA double‐strand breaks. Immune Activation: Cytosolic DNA from damaged cells activates the cGAS‐STING pathway, triggering IRF3/NF‐κB‐mediated type I interferon production. This enhances dendritic cell
Zhigang Fu   +4 more
wiley   +1 more source

The NOS score of studies for radiation pneumonitis.

open access: yes, 2016
The NOS score of studies for radiation pneumonitis.
Wenwu He (2556745)   +6 more
core   +1 more source

Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer

open access: yesBreast Cancer Research
Background Trastuzumab deruxtecan (T-DXd) is FDA-approved for treatment of patients with HER2 positive and HER2-low metastatic breast cancer. Currently, there is limited understanding of pre-treatment risk factors for pneumonitis associated with T-DXd ...
Jonathan Henricks   +15 more
doaj   +1 more source

Normal tissue complication probability models of late cardiopulmonary toxicity following deep inspiration breath hold for breast cancer adjuvant radiotherapy

open access: yesPrecision Radiation Oncology, Volume 10, Issue 3, Page 307-318, September 2026.
Deep inspiration breath hold (DIBH) markedly cuts heart and left lung radiation doses during left‐sided breast cancer radiotherapy. The normal tissue complication probability (NTCP) model further confirms lower predicted cardiopulmonary toxicities versus free breathing (FB), potentially improving patients’ quality of life.
Lin Lin   +10 more
wiley   +1 more source

Radiation Pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model

open access: yes, 2000
Background: Toxicity of the respiratory system is quite common after radiotherapy of thoracic tumors; breast cancer patients represent one of the groups for which there is also a long expected survival.
LAX I   +7 more
core   +1 more source

Precise delineation of radiation targets for thoracic tumors in the immunotherapy era: From immune mechanisms to clinical practice

open access: yesPrecision Radiation Oncology, Volume 10, Issue 3, Page 371-387, September 2026.
RT‐immunotherapy synergy for thoracic tumors relies on precise target delineation to protect immune components. IFI, reduced volumes, and optimized positioning minimize damage, while multimodal imaging, DL, PBT, and FLASH‐RT enhance control. These innovations shift RT to an immune‐centric model, improving lung and esophageal cancer outcomes.
Xiaoying Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy